Fidelity Investments’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Other funds holding LFCR
Fidelity Investments's LFCR Position: Q3 2026 in Review
Fidelity Investments reduced its Lifecore Biomedical (LFCR) stake by 84% in Q3 2026, selling an estimated $39.3K and leaving 1,622 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4924.
Fidelity Investments first reported a position in LFCR in Q2 2013 and has held it in 21 quarters since. The position peaked at $23.3M in Q2 2013. 105 funds tracked by Wall St. Rank hold LFCR as of Q3 2026.
- Fidelity Investments held 1,622 shares of Lifecore Biomedical worth $10.7K as of Q3 2026.
- Fidelity Investments sold 8,479 Lifecore Biomedical shares in Q3 2026, an estimated $39.3K.
- Lifecore Biomedical made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #4924 holding.
- Fidelity Investments first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 21 quarters since.
- Fidelity Investments's Lifecore Biomedical position peaked at $23.3M in Q2 2013.
- 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.